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We propose a new approach to microwave breast tumor sensing and diagnosis based on the use of biocompatible flagellated
magnetotactic bacteria (MTB) adapted to operate in human microvasculature. It has been verified experimentally by Martel et
al. that externally generated magnetic gradients could be applied to guide the MTB along preplanned routes inside the human
body, and a nanoload could be attached to these bacterial microbots. Motivated by these useful properties, we suggest loading
a nanoscale microwave contrast agent such as carbon nanotubes (CNTs) or ferroelectric nanoparticles (FNPs) onto the MTB in
order to modify the dielectric properties of tissues near the agent-loaded bacteria. Subsequently, we propose a novel differential
microwave imaging (DMI) technique to track simultaneously multiple swarms of MTBmicrobots injected into the breast. We also
present innovative strategies to detect and localize a breast tissue malignancy and estimate its size via this DMI-trackable bacterial
microrobotic system. Finally, we use an anatomically realistic numerical breast phantom as a platform to demonstrate the feasibility
of this tumor diagnostic method.
1. Introduction
In recent years, there have been considerable efforts in
applying microwave technology for early-stage breast cancer
detection [1].This imagingmodality attempts to discriminate
breast tissues based on their dielectric properties, which are
sensitive to physiological or pathological conditions such as
water content, temperature, and vascularization. However,
the effectiveness of microwave medical imaging is consider-
ably influenced by clutter interference due to healthy tissue
inhomogeneities [2]. This problem can be possibly solved by
using a contrast agent such as carbon nanotubes (CNTs) [3]
or ferroelectric nanoparticles (FNPs) [4] to change the tumor
tissue dielectric values. These agents can be transported
selectively to cancer cells via systemic administration for spe-
cific and noninvasive diagnosis of tissue malignancies within
specified regions-of-interest (ROI).These contrast media can
also be employed in medical therapeutic applications such as
microwave hyperthermia treatment [3].
However, contrast-enhanced microwave cancer therano-
stics is compromised by currently available targeting tech-
niques, which have limited efficacy due to intratumoral pen-
etration limitations and the presence of quiescent cells within
tumors [5]. As a result, only a small amount of contrast
agent is able to enter cancer cells. Recent advance in micro-
nano biorobotics has promised a potential remedy for this
problem through the prospect of utilizing biocompatible
flagellated magnetotactic bacteria (MTB) with nanometer-
sizedmagnetosomes acting like computer-controlledmedical
microbots. Their swimming directions and displacement
speeds can be regulated by an externally applied magnetic
field [6, 7] to deliver effectively a nanoload such as contrast
agents to a tumoral region in the human body, offering
new possibilities for breast cancer detection in microwave
tomographic [8] and radar-based [9] approaches. A tactic
for MTB-oriented microwave breast cancer detection was
suggested in [10], where each time a single swarm of MTB
microbots loaded with a nanoscale contrast agent is injected
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into the breast from a predefined injection site.Themicrobots
will navigate towards the direction of an externally exerted
magnetic gradient and its movement could potentially be
tracked by using the differential microwave imaging (DMI)
algorithm proposed in [11]. In theory, when a particular
microbot trajectory would meet a tumor, the contrast agent
will be discharged from the microbots and attached to cancer
cell receptors. Subsequently, these miniature biorobots will
no longer be trackable by the DMI system, which only
detects difference in the tissue dielectric properties caused
by the agent. Therefore, a DMI footprint “sink” inside breast
would emerge at the tumor location where the contrast agent
accumulates eventually.
The current work extends the results in [10] by consid-
ering multiple agglomerations of MTB, which are injected
concurrently into breast at each round of operation to reduce
the diagnostic time. Our previous DMI algorithm [11] is only
applicable to the location estimation of the nearest microbot
swarm. Consequently, in order to track multiple swarms,
the antennas of the DMI apparatus should be divided into
several groups. Each group only tracks its nearest swarm. By
enforcing the constraint that DMI footprints should be nearly
aligned with the a priori known magnetic field, the average
dielectric properties of breast can be approximated and the
microbot swarms are tracked. Furthermore, as a significant
extension to [12], we provide a comprehensive discussion on
themain characteristics of theMTB as an ideal contrast-agent
transporter and propose to deploy them to target possible
tumor locations from different angles in order to reduce false
alarms and possibly estimate the tumor size via registration
of multiple final footprints around the tumor border.
It is worth noting that the proposed technique for detec-
tion of tumors is an extrapolation of laboratory-verified tech-
niques and is applied to the problem of breast cancer sensing.
The current work represents an early-stage exploration of this
approach.
The remainder of the paper is organized as follows. In
Section 2, we highlight some key properties of the controll-
able MTB actuators, which have been demonstrated experi-
mentally by Martel et al. [6, 7]. We also present the general
principle of tumor sensing and diagnosis. In Section 3, we
describe possible schemes to detect and localize a breast tissue
malignancy and estimate its size through the DMI-trackable
bacterial propulsion-and-steering platform. In Section 4, we
study the feasibility of the proposed strategies using an
anatomically realistic breast model from the University
of Wisconsin Computational Electromagnetics (UWCEM)
Laboratory’s Breast PhantomRepository [13]. Finally, we con-
clude with discussion on the potential and future extension of
our approach in Section 5.
2. Bacterial Microbots for
Direct Tumor Targeting
2.1. Main Characteristics of MTB. A flagellated MTB can be
considered as a sophisticated cargo carrier with an embedded
control interface, which comprises the following components
as illustrated in Figure 1: (i) a steering wheel controlling
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Propeller
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Figure 1: Key functional elements of MTB.
remotely the direction in which the MTB move (i.e., a chain
of magnetosomes imparting to the MTB a magnetic moment
so that the bacterium can align itself to an external magnetic
field); (ii) propellers as the propulsion engines accelerat-
ing the MTB to move towards a targeted destination (i.e.,
two flagellar bundles allowing the bacterium to swim in a
medium); (iii) a fuel unit powering all the components by
scavenging energy from external sources (i.e., a nutrients-to-
protons converter); and (iv) sensors acting as the interface
between the environment and the MTB (i.e., receptor chan-
nels for chemotaxis or aerotaxis to detect nutrient gradients).
As shown in the previous works by Martel et al. [6, 7, 14–
17], MTB exhibit the following desirable properties making
them ideal controllable bacterial actuators for direct tumor
sensing.
2.1.1. Speed and Size. Magnetotactic cocci cells (e.g., the
MC-1 bacteria) can achieve an average velocity of 200 𝜇m/s
in human blood with a peak velocity of 300 𝜇m/s. This is
much faster than many other flagellated bacteria (30 𝜇m/s)
and the synthetic artificial flagella in the form of nanocoils
actuated by a rotating magnetic field (4.6 𝜇m/s). The max-
imum velocity could be maintained even when the MTB
were loaded with an average of 70 liposomes with an overall
diameter exceeding 150 nm, suggesting the possibility of
attaching a wide variety of nanoscale elements to the surface
of its cell. The cell of the MC-1 MTB is spherical in shape
with a diameter of ∼2 𝜇m being approximately half the
diameter of the smallest capillaries in human, making it ideal
for transiting in the tiniest blood vessels.
2.1.2. Propulsion and Steering. The two flagellar bundles of
the MC-1 MTB provide a thrust force exceeding 4 pN, which
is much higher than other flagellated bacteria (0.3–0.5 pN).
When subject to a magnetic field higher than 4 Gauss, the
directional motions of the MTB were mainly influenced by
magnetotaxis (i.e., aligned to magnetic field lines) as com-
pared to chemotaxis (i.e., moving towards or away from a
chemical source) and aerotaxis (i.e., moving towards or away
from air or oxygen), thus fully remotely controllable using
appropriate electronic hardware and software.
2.1.3. Byproducts of Bacterial Degradation. The degrada-
tion byproducts of the nonpathogenic bacteria could have
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a cytotoxic effect at high concentration, which imposes a limit
on the amount of MTB that could be present in the human
body at any time. Preliminary results showed that the cell
viability was higher than 90% for 80 𝜇L of bacteria solution
(5 × 104 cells/200 𝜇L in cell culture solution) in a 200 𝜇L
well, indicating the noncytotoxic effect of the bacteria at this
concentration.
On the other hand, initial experiments conducted in
human blood at 37∘ showed that the velocity 𝑉 (in 𝜇m/s) at
a time 𝑡 (expressed in minutes) after the beginning of opera-
tions of the MC-1 MTB decreased according to
𝑉 = 0.09𝑡2 − 8.10𝑡 + 𝑉0, 0 ≤ 𝑡 ≤ 40 min, (1)
where 𝑉0 ≈ 200 𝜇m/s is the initial average velocity of the
MTB prior to being injected into blood. The MC-1 MTB
would remain effective for at least 40 minutes, and the
decrease in speed was probably caused by the relatively high
temperature of blood. This is beneficial from the perspective
of biocompatibility and safe in vivo operations but limits the
time at which the MC-1 MTB could operate. As a rough
estimate, the average distance that could be traveled by an
effective MC-1 MTB in the human body is given by ∫40
0
𝑉 ⋅60d𝑡 ≈ 21 cm, which is sufficient for the application of breast
cancer theranostics.
2.1.4. Loading and Targeting. The delivery of a contrast agent
to a tumoral lesion requires transitions through capillary
sections of human microvasculature. The loading strategy
depicted in Figure 1 can utilize antibodies specific to MC-1
cells or another effective method based on chemical bound-
ing (see, e.g., [6]).The nanocomposites such as CNTs or FNPs
can be functionalized by means of proper molecular groups
such as peptides or antibodies, which are able to bind to
cancerous cell receptors.
In order to deliver sufficient amounts of contrast agent
to a tumor, a cluster of MC-1 MTB can be deployed simul-
taneously. It has been demonstrated that an agglomeration
of MC-1 cells could be controlled like a unified organism to
swim along a predetermined path by an external computer
[14]. Finally, it has been shown using an in vitro model
that MTB guided by magnetic fields could penetrate inside
a multicellular tumor spheroid. As many tumors contain
vasculogenic mimicry [18], these channels should help MTB
to be evenly distributed inside a tumor.
2.1.5. Aggregation of MTB. A relatively weak magnetic gra-
dient could be generated towards an aggregation zone, whose
size can easily be in the millimeter range. The boundary of
the aggregation zone is equivalent to approximately 0.5Gauss
with the center at 0 Gauss. When outside the aggregation
zone, the bacteria follow the line of magnetic field. When
inside the zone, the MTB are no longer influenced by
magnetotaxis and begin random motions. If the MTB exit
the aggregation zone, the magnetic field forces the MTB to
move back to the zone bymagnetotaxis. To improve targeting
effectiveness, various magnetic field modulation modes have
been developed depending on the characteristics of the
Magnetic gradient
Biological object
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Footprint “sink”
DMI footprint
(Aggregation zone)
Actual MTB path
MTB swarms 1 and 2
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(b)
Figure 2: Illustration of (a) cancer detection and (b) examination
with multiswarm MTB microbots.
angiogenesis network, that is, the capillary network feeding
the tumor or the surrounding tissue. Once targeting has been
completed, imaging could be performed to assess targeting
efficacy and to confirm the region being affected. If needed,
the operation can be repeated towards another targeted area
by setting the aggregation zone accordingly.
2.2. Cancer Detection and Diagnosis with MTB Microbots.
We illustrate the rationale for cancer detection and diagnosis
with multiswarm MTB microbots in Figure 2(a), where two
clumps of MTB are used as an example. Consider that
these MTB are loaded with a microwave agent and injected
simultaneously into the human body from two separate
injection sites. An external source creates a magnetic field by
means of a wire or coils placed close to the biological object
under examination. As shown in Figure 2(a), we assume that
the resultingmagnetic field lines are concentric circles, which
determine the direction in which the MTB will align. Apart
frommagnetotaxis, theMTB paths aremainly constrained by
microvasculature networks in the breast. Hence, the move-
ment of MTB is not directly affected by the heterogeneity
within the breast.
We extend theDMI algorithmproposed in [11] tomultiple
targets as to be discussed in Section 3.2. This method is then
utilized to track the motions of these two agglomerations of
microbots by detecting and localizing the change in tissue
dielectric properties in the targeted MTB aggregation zones
4 International Journal of Antennas and Propagation
as illustrated in Figure 2(a). Consequently, the measured
DMI footprints corresponding to these aggregation zones
result in snapshots of the actual MTB paths as illustrated in
Figure 2(a). If a swarm of MTB microbots fails to detect a
tumor (i.e., the corresponding microbot path does not cross
the tumor), it will keep navigating towards the magnetic
gradient until being maneuvered out of the human body. On
the other hand, if the swarm senses a tumor, the contrast
agent will be removed from the swarm and bound to cancer
cell receptors. After load discharging, this swarmwill become
invisible to the DMI system, which only tracks variation in
tissue dielectric properties caused by the agent. Hence, the
locationwhere the contrast agent finally accumulateswill give
rise to a “sink” on the preplanned MTB pathway as shown in
Figure 2(a). Multiple tissuemalignancies will result in several
DMI footprint “sinks.” Hence, tumors can be detected via this
seeing-is-sensing principle.
On the other hand, we could inject MTB to target a
detected and localized tumor from various directions as
depicted in Figure 2(b).This can be achieved by using several
magnetic field sources using, for example, direct current
(dc) sources placed at different locations. These fields would
guideMTB along distinct pathways to reach cancer cells from
different angles. In this way, the final footprints immediately
before a “sink” is observed would be scattered around the
tumor edge. The tumor size which is related to the stage
of breast cancer can thus be estimated via registration of
all the final footmarks as demonstrated in Figure 2(b). This
additional information will also help reduce false alarms for
possible tumor locations. Hence, a tumor could be examined
via this seeing-is-examination principle.
In the next section, we present possible strategies for the
implementation of these approaches.
3. Strategies for Breast Cancer Detection,
Localization, and Size Estimation
3.1. Proposed System Architecture and Protocol. To elaborate
on our approaches, we consider a “heterogeneously dense”
numerical phantom from the UWCEM breast model reposi-
tory [13], which also includes one tumor having the median
dielectric properties of malignant breast tissue [2]. Similar
to [8, 11], we employ the forty-element dipole antenna array
arranged over five circular rings as shown in Figure 3(a).
We plan to implement two-dimensional (2D) tumor sensing
along the cross-sectional planes of the rings using three-
dimensional (3D) DMI data. For illustrative purpose, we
focus on the third cross-sectional plane from the top, which
slices through the tumor.The corresponding dielectric profile
is shown in Figure 3(b). We apply the monostatic data
obtained at the eight antennas of the third ring for tumor
sensing. It is assumed that the presence of a contrast agent in
a tissue region will substantially alter its dielectric properties
[3]. As outlined in Section 2.2, our aim is to use the DMI
algorithm to track the MTB swarms by sensing the induced
changes in the surrounding tissue dielectric values. An
important side result is the estimation of the breast average
properties.
A block diagram representing the system architecture of
breast tumor detection and diagnosis with multiswarmMTB
microbots is shown in Figure 4. The basic sequence of events
is detailed as follows.
3.1.1. Initialization. Prior to the injection of contrast-agent-
loaded microbots, we consecutively transmit ultra-wideband
(UWB) probing waveforms from each antenna element as
shown in Figure 3(b) and record the signals reflected from
the breast at each element. These backscatter responses for
the agent-free breast will be used for benchmarking during
the DMI procedure at a later step.
3.1.2. Propulsion and Steering. We design the in-body micro-
bot routes based on the breast geometry as well as the ROI in
its interior and identify the corresponding injection sites on
the breast surface. The ROIs may be acquired by using some
preprocessing procedures (e.g., a noninvasive tomographic
approach). The better the ROIs can be defined, the better the
MTB paths can be planned. From this perspective, the system
performance also depends on having a good-quality initial-
stage imaging system. The path planning should ensure that
the entire ROI where cancers may be present is covered
with sufficiently small intervals between neighboring paths
to reduce the probability of miss. To reduce sensing time,
we inject multiple swarms of agent-loaded microbots into
the breast. Note that we do not produce the magnetic field
in our simulations but assume that its effect is to guide the
swarms along concentricmagnetic field lines generated at one
of the eight antennas for a specific interval 𝑡PS until they reach
the targeted aggregation zones as illustrated in Figure 3(b).
During traveling to the aggregation zone, the microbots are
not detected because they swim at different velocities and as
such they disperse, making the density too low for tracking.
3.1.3. Tracking. Subsequently, we switch the system opera-
tional mode from “propulsion-and-steering” to “tracking.” In
order to set two aggregation zones simultaneously, we employ
the following time-multiplexing scheme at a high frequency:𝑇M1 → 𝑇M2 → 𝑇A1 → 𝑇M1 → 𝑇M2 → 𝑇A2 →⋅ ⋅ ⋅ . During 𝑇M1 and 𝑇M2 , two magnetic gradients are gen-
erated to set the two aggregation zones. Furthermore, during𝑇A𝑖 (𝑖 = 1, 2, . . . , 8), the waveform used in the initialization
phase is retransmitted from the 𝑖th antenna element, and
the corresponding backscatter response is recorded. We then
apply the DMI algorithm to track multiple swarms within
their respective aggregation zones.The size of the aggregation
zones is in the range of 2mm, which is much smaller than the
cancerous lesion to be detected.
3.1.4. Decisionmaking. We then confirm whether the tumor
sensing is completed, given the microbot footmarks and
subject to a number of criteria as listed in Figure 4. We
need to check whether the swarms of microbots are still
present in the breast, whether aDMI footprint “sink” has been
observed, and whether all the preplanned paths have been
completed. If all the answers are confirmative, we declare that
tissue anomalies have been positively detected. Otherwise,
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Figure 3: (a) Illustration of the tumor sensing and diagnosis system using a configuration similar to [8, 11]. (b) Dielectric profile at 1GHz
for the coronal cross-section through the third antenna ring. We assume concentric magnetic field lines originating from a dc source via
one of the antennas (marked with a “+”) during the propulsion-and-steering phase. All the eight antennas probe the breast sequentially with
UWB pulses during the tracking phase after the MTB reach the targeted aggregation zones (marked with yellow circles). Two clumps of
MTB are injected simultaneously into the breast. (c) Size estimation of the tumor by targeting it from different angles; the eight antennas are
sequentially employed to carry a dc for generation of magnetic fields.
the system may inject new agglomerations of microbots or
continue maneuvering the old ones, depending on whether
the previously deployed swarms are still in the breast. It is
worth noting that all the preplanned microbot trajectories
should be completed even if a tumor has been detected. This
is to ensure successful detection and targeting of multiple
cancerous masses.
3.1.5. Multidirectional Targeting. Provided with the a priori
knowledge of the tumor location acquired in the previous
steps, we then replan the microbot paths and injection
sites in order to target the tumor from different angles as
demonstrated in Figure 3(c). The survey plan should ensure
that these angles-of-arrival are evenly distributed between 0
and 2𝜋 to facilitate a full 360-degree view of the tumor. A
possible strategy is shown in Figure 3(c), where each antenna
(indexed from 1 to 8) takes turn to carry a dc for generation
of magnetic fields. Suppose that we have extracted the rough
position of a tumor through the previous operations. For each
dc excitation, we can identify a few adjacent infusion sites
on the breast surface as shown in Figure 3(c). These sites are
selected such that theoretical microbot paths originated from
them may intersect at the tumor. For illustrative purposes,
we draw one path (marked with the antenna index) for
each antenna as depicted in Figure 3(c). We then admin-
ister multiswarm MTB microbots and perform propulsion,
steering, and tracking until all the “sinks” are observed. If
the distance between two successive footprints is sufficiently
small, the final DMI footprints providemarkers on the tumor
edge and therefore could be used to approximate its size.
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Start
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Plan MTB paths and injection sites
to target the tumor from many
different directions
Perform propulsion/steering/tracking of MTB until all “sinks” are seen
Multidirectional targeting
Release multiple swarms of
contrast-agent-loaded MTB
Registration of all final footprints for tumor size estimation
Apply magnetic fields for a specified period tPS
Figure 4: Flowchart representing the system architecture of breast tumor detection and diagnosis with multiswarm MTB microbots.
This additional step also helps reduce false alarms for tumor
detection and localization by exploiting the microbot path
diversity.
3.2. Tracking of Multiple Swarms of MTB Microbots. In this
section, we present a novel DMI algorithm to detect multiple
local dielectric variations due to multiswarm contrast-agent-
loaded MTB microbots. We can summarize the principles
of the algorithm as follows. A microwave contrast agent
such as CNTs or FNPs loaded onto multiple aggregations
of MTB changes the local dielectric properties of the tis-
sue regions where the MTB are present. We can extract
the difference between the backscatter responses before and
after the injection of MTB over time. We then formulate
the problem from the perspective of signal model selection
(differential signal corrupted by noise versus noise alone) and
apply the information theoretic criterion such as the Akaike
information criterion or the minimum description length
to reliably estimate the locations of the induced dielectric
changes [11].
We consider a cluttered breast medium as shown in
Figure 5. Two swarms of MTB microbots are present in
the interference-prone biological environment with a large
number of normal breast tissue inhomogeneities. Consider
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Figure 5: An interference-prone breast channel where two agent-
loaded MTB swarms are present in the cluttered breast with tissue
inhomogeneities. A radar system containing multiple spatially
diverse monostatic antenna elements is deployed for tracking the
swarms.
a radar system comprising multiple monostatic antenna
elements, A1,A2, . . . ,A𝑍. Each antenna represents both a
source and a sensor of the electromagnetic signals. We will
use the subscript 𝑧 in all the following analyses to indicate
the quantities associated with antenna A𝑧 (𝑧 = 1, 2, . . . , 𝑍).
Let 𝑠𝑧(⋅) and 𝑜𝑧(⋅) denote, respectively, the discrete-time
transmitted and received signals byA𝑧.The following general
relationship can be obtained:
𝑜𝑧 (𝑚) =
𝐿𝑧−1∑
𝑙=0
ℎ𝑧 (𝑙) 𝑠𝑧 (𝑚 − 𝑙) + 𝑢𝑧 (𝑚) , (2)
where ℎ𝑧(⋅) is the discrete channel response, 𝑢𝑧(⋅) is the
additive white Gaussian noise (AWGN), and 𝐿𝑧 denotes the
order of the discrete channel. Equation (2) can be rewritten
in the matrix form as
o𝑧 = H𝑧s𝑧 + u𝑧, (3)
where
o𝑧=[𝑜𝑧((𝑛 − 1)(𝐿𝑧 +𝑀𝑧 − 1) + 1) ⋅ ⋅ ⋅ 𝑜𝑧(𝑛(𝐿𝑧 +𝑀𝑧 − 1))]𝑇,
H𝑧=
[[[[[[[[[[[[[
[
ℎ𝑧 (0)ℎ𝑧 (0) ℎ𝑧 (1)
...
...
...ℎ𝑧 (0) ℎ𝑧 (1) ⋅ ⋅ ⋅ ℎ𝑧 (𝑀𝑧 − 1)ℎ𝑧 (1) ℎ𝑧 (2) ⋅ ⋅ ⋅ ℎ𝑧 (𝑀𝑧)
...
...
...ℎ𝑧 (𝐿𝑧 − 2) ℎ𝑧 (𝐿𝑧 − 1)ℎ𝑧 (𝐿𝑧 − 1)
]]]]]]]]]]]]]
]
,
s𝑧=[𝑠𝑧(𝑛𝑀𝑧) ⋅ ⋅ ⋅ 𝑠𝑧((𝑛 − 1)𝑀𝑧 + 1)]𝑇,
u𝑧=[𝑢𝑧((𝑛 − 1)(𝐿𝑧 +𝑀𝑧 − 1) + 1) ⋅ ⋅ ⋅ 𝑢𝑧(𝑛(𝐿𝑧 +𝑀𝑧 − 1))]𝑇.
(4)
In (4), 𝑛 = 1, 2, . . . , 𝑁 is the index of each observation. o𝑧,H𝑧,
s𝑧, and u𝑧 are the (𝐿𝑧 + 𝑀𝑧 − 1) × 1 observation vector, the(𝐿𝑧 +𝑀𝑧 − 1) ×𝑀𝑧 channel matrix, the𝑀𝑧 × 1 source signal
vector, and the (𝐿𝑧 + 𝑀𝑧 − 1) × 1 noise vector, respectively.
The symbol 𝑇 denotes matrix transpose.
Suppose that the delay taps introduced by these two
swarms of agent-attached microbots are ℓ1,𝑧 and ℓ2,𝑧 (0 <ℓ1,𝑧, ℓ2,𝑧 ≤ 𝐿𝑧 − 1). The presence of contrast media in the
breast will distort the biological channel response by inducing
changes in the tissue dielectric properties. We note that only
late responses with delays greater than L𝑧 = min{ℓ1,𝑧, ℓ2,𝑧}
will be affected. Hence, the new channelmatrix after injection
of MTB is
H̃𝑧 = H𝑧 + ΔH𝑧, (5)
where the (𝑖, 𝑗)th (𝑖 = 1, 2, . . . , 𝐿𝑧 +𝑀𝑧 − 1; 𝑗 = 1, 2, . . . ,𝑀𝑧)
entry of the perturbation matrix ΔH𝑧 is expressed as
ΔH𝑧 [𝑖, 𝑗] =
{{{{{
0; if H𝑧 [𝑖, 𝑗] = 00; if H𝑧 [𝑖, 𝑗] = ℎ𝑧 (𝑙) and 𝑙 <L𝑧Δℎ𝑧 (𝑙) ; if H𝑧 [𝑖, 𝑗] = ℎ𝑧 (𝑙) and 𝑙 ≥L𝑧.
(6)
In (6), Δℎ𝑧(𝑙) is a nonzero term summarizing the overall
perturbation effect introduced to the 𝑙th tap of the biological
channel.
Subsequently, we can split all antennas into two groups
as shown in Figure 5. For each member in antenna group𝑘 (𝑘 = 1, 2), L𝑧 = ℓ𝑘,𝑧, and each group only detects its
nearest microbot swarm. As a result, we can apply readily
the information-theoretic-criteria-based DMI algorithm in
[11] for single-target localization, where the time-of-arrival
(TOA) of the backscatter from the swarm,L𝑧, is estimated.
If the microbot paths are planned such that the two swarms
are well separated in the breast at all time instants, it is
straightforward to perform antenna grouping, knowing the
locations of the injection sites and the dc source.
3.3. TOA Data Fusion for Unknown Average Tissue Dielec-
tric Properties. To estimate the cancer location, the TOAs
measured at different antennas can be combined by using
the data fusion method proposed in [19]. This algorithm,
however, requires knowledge about the average tissue dielec-
tric properties, which is very difficult to obtain in a real-
life clinical setting. The current tumor sensing strategy offers
an interesting way to overcome the above challenge by
estimating both the average wave propagation speed and the
swarm location in the breast. We assume that an antenna
A𝑧𝑘 (𝑘 = 1, 2) is tracking the 𝑘th microbot swarm. A𝑧𝑘 is
located at (𝑥𝑧𝑘 , 𝑦𝑧𝑘) and measures a TOA 𝜏𝑧𝑘 =L𝑧𝑘𝑇0, where𝑇0 is the sampling time.The TOA 𝜏𝑧𝑘 defines a circle centered
atA𝑧𝑘 with radius 𝑟𝑧𝑘 = V𝜏𝑧𝑘/2, where V is the average speed of
electromagnetic waves in the breast medium and is related to
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the mean tissue permittivity 𝜀𝑏 and conductivity 𝜎𝑏 through
the following relationship:
V = 1
√(𝜇0𝜀𝑏/2) [√1 + (𝜎𝑏/𝜔𝜀𝑏)2 + 1]
.
(7)
As knowledge of the TOA estimation error statistics is not
available, we locate the 𝑘th microbot swarm by minimizing
the sum of square of the distances from the swarm to the
points of intersection of the range circles closest to it. The
objective function is given by
x̂𝑘 = arg minx𝑘 {{{
𝐽𝑘∑
𝑗𝑘=1
󵄩󵄩󵄩󵄩󵄩x𝑘 − x𝑗𝑘󵄩󵄩󵄩󵄩󵄩2}}}
. (8)
The parameter 𝐽𝑘 is the total number of intersection points.
x𝑘 = [x𝑇𝑘,0, 𝛿1, . . . , 𝛿𝑍𝑘]𝑇, where x𝑘,0 = [𝑥𝑘, 𝑦𝑘]𝑇 is the true
position of the 𝑘th swarm, 𝛿𝑧𝑘 represents the value of distance
measurement error betweenA𝑧𝑘 and the swarm, and𝑍𝑘 is the
cardinality of antenna group 𝑘. x𝑗𝑘 = [x𝑇0,𝑗𝑘 , 0, . . . , 0]𝑇, where
x0,𝑗𝑘 = [𝑥𝑗𝑘 , 𝑦𝑗𝑘]𝑇 is the 𝑗𝑘th intersection.
Let c𝑘 = (1/𝐽𝑘) ∑𝐽𝑘𝑗𝑘=1 x0,𝑗𝑘 be the center of all intersection
points, and let 𝑑𝑧𝑘(c𝑘) = √(𝑥𝑧𝑘 − 𝑥c𝑘)2 + (𝑦𝑧𝑘 − 𝑦c𝑘)2 be the
distance betweenA𝑧𝑘 and c𝑘 = [𝑥c𝑘 , 𝑦c𝑘]𝑇. Given an average
speed of waves V, an optimumnoniterative solution of (8) can
be written as [19]
x̂𝑘 (V) = Ω𝑇𝑘 (Ω𝑘Ω𝑇𝑘 )−1 (r𝑘 − d𝑘) + 1𝐽𝑘
𝐽𝑘∑
𝑗𝑘=1
x𝑗𝑘 , (9)
where
(i) Ω𝑘 = [[
[
(𝑥c𝑘−𝑥1)/𝑑1(c𝑘) (𝑦c𝑘−𝑦1)/𝑑1(c𝑘) 1 ⋅⋅⋅ 0
...
...
... d
...
(𝑥c𝑘−𝑥𝑍𝑘 )/𝑑𝑍𝑘 (c𝑘) (𝑦c𝑘−𝑦𝑍𝑘 )/𝑑𝑍𝑘 (c𝑘) 0 ⋅⋅⋅ 1
]]
]
,
(ii) r𝑘 = [𝑟1, . . . , 𝑟𝑍𝑘]𝑇 is the range measurements vector;
and
(iii) d𝑘 = [𝑑1(c𝑘), . . . , 𝑑𝑍𝑘(c𝑘)]𝑇 is the distance vector.
The detailed derivation of (9) can be found in [20].
Finally, we enforce the constraint that DMI footprints
should be roughly aligned with the theoretical circular
magnetic field with radius 𝑅 generated by a dc source located
at xdc = [𝑥dc, 𝑦dc]𝑇. As a result, the average speed V is
estimated to be
V∗ = arg minV 󵄨󵄨󵄨󵄨󵄩󵄩󵄩󵄩x̂𝑘 (V) − xdc󵄩󵄩󵄩󵄩 − 𝑅󵄨󵄨󵄨󵄨 (10)
and the corresponding swarm footprint is given by x̂𝑘(V∗).
4. Simulation Results
We use several numerical examples to elaborate on the afore-
mentioned cancer detection and diagnosis methods. Specifi-
cally, we simulate possible movements of the swarms due to
the presumed magnetic field and test the ability of the DMI
algorithm for tracking the microbot trajectories and sensing
the tumor. Figure 3 provides the layout of the microbots-
assisted diagnostic system as discussed in Section 3. The
injection sites are spaced on the circumference of the cross-
section of the numerical phantom shown in Figure 3(b),
which is also illustrated in Figure 6(a) (marked with circles).
Figure 6(a) also shows the preplanned microbot paths cov-
ering uniformly the two ROIs in the breast interior. The
gap between two neighboring pathways is ∼5mm, which
gives rise to the resolution of the specific survey plan. Two
microbot swarms are injected into the breast simultaneously,
where their injection sites are spaced apart during the whole
sensing process to ensure reliable tracking as discussed
in Section 3.2. We assume that each swarm of microbots
follows a directional random walk during the propulsion-
and-steering stage. Thus, each step size fluctuates according
to an exponential probability density function (pdf) with a
mean value 𝛽. Furthermore, the direction at each step is
uniformly distributed between [𝜑 − 𝜃, 𝜑 + 𝜃]. The parameter𝜑 is the average direction towards the magnetic gradient and𝜃 characterizes the effect of directional disturbance due to
other gradients such as chemotaxis and aerotaxis as well as
randommicrovasculature structures. Finally, we assume that
the microbots in the aggregation zones follow an isotropic
random walk with the same step size distribution as the one
used in the tracking stage, which has been demonstrated
experimentally [6, 7, 14–17].
The initial velocities of both swarms are assumed to be200 𝜇m/s, which decrease with time after being injected into
the breast according to (1). The duration for the propulsion-
and-steering phase is 𝑡PS = 2min. To synthesize the effect
of contrast-agent-loaded microbots on the tissue dielectric
properties, we adopt CNTs as the agent to modify the
dielectric properties for one 2 × 2 × 2mm3 cubic voxel inside
the breast phantom. We assume that the relative permittivity
and conductivity of this voxel are 22% and 70% higher than
the median properties of malignant breast tissue, following
the measurement data in [8].
Each dipole antenna in Figure 6(a) is driven with a
modulated Gaussian pulse having a bandwidth covering0.5 to 3.5GHz, and the backscatter signal is recorded at
the same antenna (monostatic configuration). The signal-to-
noise ratio (SNR) used in our simulation study is 10 dB.
Figure 6(b) shows a typical simulated sensing pro-
cess (𝜃 = 30∘, 𝛽 = 100 𝜇m) and plots the associated DMI
footprints. Samples of the exact locations ofmicrobots during
the tracking phase are marked with triangles, and the cor-
responding location estimates are marked with squares. For
example, consider two swarms injected simultaneously from
the 1st and the 4th injection sites. These two agglomerations
of microbots were directed by the magnetic fields to swim
for 2min and reach the first aggregation zones where the
tracking was performed. Once the tracking is completed, the
system mode was switched back to propulsion-and-steering.
The swarms continued navigating and the DMI algorithm
presented in Section 3.2 was applied to locate the microbots
for the earlier tracking cycle. The same steps were repeated
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Figure 6: (a) Preplanned MTB paths for the system setup in Figure 3(b). (b) Simulated DMI footprints. The MTB injection sites are marked
with “∘.” The actual and estimated positions of the MTB during the tracking phase are marked with “󳵻” and “◻,” respectively. The estimated
final destination of contrast agent (i.e., DMI footprint “sink”) is marked with “󳀅.” (c) Sensing time versus angular spread 𝜃 andmean step size𝛽 of the directional random walk for single- and two-swarm administration. The fixed parameter values are 𝛽 = 100 𝜇m in the former and𝜃 = 30∘ in the latter. The markers “×” and “∘” correspond to the sensing time mean and dispersion, respectively.
periodically. When any of the two swarms left the breast,
we injected a new agglomeration of microbots from the next
injection site, and so on.The overall good agreement between
the estimated and exact microbot locations demonstrates the
feasibility of the proposed DMI algorithm for tracking the
CNTs-loadedMTBmicrobots. Ideally, a DMI footprint “sink”
indicating the cancer location will be recorded, as described
in Section 3. Finally, two additionalmicrobot injections at the
bottom of the breast are required to complete the original
path plan shown in Figure 6(a).
The angular spread 𝜃 and the mean step size 𝛽 of the
random walk process will affect the cancer diagnostic
time, which is an important system performance metric.
Figure 6(c) shows themean,maximum, andminimum tumor
sensing times for various 𝜃 and 𝛽 by carrying out ten inde-
pendent simulations of themicrobot tracking process. Appar-
ently, by exploiting two swarms of microbots in parallel,
remarkable reduction in the time spent in completing the
breast examination is achieved as compared to the single-
swarm case. Moreover, the mean and dispersion of the
sensing time increase with the angular spread 𝜃, while the
average sensing duration is not affected by different 𝛽 values
though its dispersion increases with 𝛽 in general.
Finally, Figure 7(a) illustrates a typical multidirectional
tumor targeting process based on the strategy presented in
Section 3.1. For each dc source, only one injection site is
designated in order to send an MTB swarm to target the
tumor location from one particular direction.We also reduce
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Figure 7: (a) Multidirectional tumor targeting. (b) Simulated DMI
footprints for four tumors with different sizes. The actual and
estimated final MTB footprints are marked with “󳵻” and “◻”,
respectively.
the propulsion-and-steering period to 10 s to ensure a more
frequent tracking process. Subsequently, Figure 7(b) demon-
strates the final footprints of MTB swarms for four tumors
with varying sizes. As can be seen from this figure, the
locations of these footprints correlate well with the size of
the tumor, which demonstrates the potential of the proposed
method for tumor size estimation.
5. Conclusion
This preliminary study presented a novel scheme for micro-
wave breast cancer detection and diagnosis with the use of
multiswarm bacterial microbots. The proposed technique is
more accurate and is inherently integrated with the follow-
up drug delivery and cancer treatment as compared to other
noninvasive imaging modalities such as X-ray, magnetic
resonance imaging (MRI), ultrasound scan, and microwave
imaging. However, it is minimally invasive due to the injec-
tion procedure of MTB. Moreover, compared to MRI-guided
tumor targeting based on MTB [14], the current approach
is much cheaper by replacing the expensive MRI equipment
with the low-cost microwave system.
Several key assumptions must be verified for these tactics
to be clinically feasible. Firstly, the efficiency of the MTB as
controlled trackable propulsion and steering systems, as well
as the ability of our proposed DMI algorithm to detect the
microbot swarms based on the effect of their contrast agent
cargos inside the tissue should be confirmed. The complex
permittivity change due to the agent-attached swarms will
depend onmany factors and must be studied further; the key
issue for the feasibility of our approach is that they induce
a change in the dielectric properties which can be detected
by our DMI technique. Secondly, due to the physiological
environment (microvasculature, tissue environment, etc.), it
is more likely that the maximum density of microbots in the
aggregation zone will be lower than the one achieved in free
space such as in water. As such, the sensitivity of the DMI
system for trackingmicrobots in the aggregation zone should
be validated experimentally. Finally, the immune response
of MTB will be investigated further (e.g., development of
mutation of the same specie of MTB for repeated operation
within a short duration).
There are many ways for improving and expanding the
capabilities of the proposed system. For example, to better
plan the swarm trajectories and ensure a good coverage
of the breast interior, a priori information could be used
from a preprocessing step of microwave tomography using
the same configuration. In addition, further postprocessing
using the differential backscatter data could infer additional
information about the lesion morphology and avoid false
detection [9], which could occur, for example, if the agent
is falsely unloaded. Multimodality imaging including MRI
will also be considered. Finally, microwave hyperthermia
treatment could be performed once the tissue malignancy is
localized and the contrast agent is successfully transported to
the tumor site thereby improving its heating response [3].
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